Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K A Neve

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Psychopharmacology|February 10, 1999
Short- and long-term heterologous sensitization of adenylate cyclase by D4 dopamine receptorsV J Watts, M N Vu, B L Wiens, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 24, 1998
Selective activation of Galphao by D2L dopamine receptors in NS20Y neuroblastoma cellsV J Watts, B L Wiens, M G Cumbay, et al.
Psychopharmacology|April 1, 1995
LSD and structural analogs: pharmacological evaluation at D1 dopamine receptorsV J Watts, C P Lawler, D R Fox, et al.
Neuroscience|July 2, 2013
Normalizing dopamine D2 receptor-mediated responses in D2 null mutant mice by virus-mediated receptor restoration: comparing D2L and D2SK A Neve, C P Ford, D C Buck, et al.
Journal of Neurochemistry|November 5, 1997
Metabolism of catecholamines by catechol-O-methyltransferase in cells expressing recombinant catecholamine transportersA J Eshleman, E Stewart, A K Evenson, et al.
European Journal of Pharmacology|August 3, 1993
Hexahydrobenzo[a]phenanthridines: novel dopamine D3 receptor ligandsV J Watts, C P Lawler, T Knoerzer, et al.
Clinical and Experimental Pharmacology & Physiology|March 4, 2000
Viral-mediated gene delivery of constitutively activated G alpha s alters vasoreactivityW E Schutzer, V J Watts, J Chapman, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1990
Sodium-dependent isomerization of dopamine D-2 receptors characterized using [125I]epidepride, a high-affinity substituted benzamide ligandK A Neve, R A Henningsen, J M Kinzie, et al.
Biochemical Pharmacology|November 15, 1988
Interaction of beta-adrenergic receptors with the inhibitory guanine nucleotide-binding protein of adenylate cyclase in membranes prepared from cyc- S49 lymphoma cellsS N Abramson, M W Martin, A R Hughes, et al.
Molecular Endocrinology (Baltimore, Md.)|July 21, 2001
Regulation of melatonin 1a receptor signaling and trafficking by asparagine-124C S Nelson, M Ikeda, H S Gompf, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Psychopharmacology|February 10, 1999
Short- and long-term heterologous sensitization of adenylate cyclase by D4 dopamine receptorsV J Watts, M N Vu, B L Wiens, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 24, 1998
Selective activation of Galphao by D2L dopamine receptors in NS20Y neuroblastoma cellsV J Watts, B L Wiens, M G Cumbay, et al.
Psychopharmacology|April 1, 1995
LSD and structural analogs: pharmacological evaluation at D1 dopamine receptorsV J Watts, C P Lawler, D R Fox, et al.
Neuroscience|July 2, 2013
Normalizing dopamine D2 receptor-mediated responses in D2 null mutant mice by virus-mediated receptor restoration: comparing D2L and D2SK A Neve, C P Ford, D C Buck, et al.
Journal of Neurochemistry|November 5, 1997
Metabolism of catecholamines by catechol-O-methyltransferase in cells expressing recombinant catecholamine transportersA J Eshleman, E Stewart, A K Evenson, et al.
European Journal of Pharmacology|August 3, 1993
Hexahydrobenzo[a]phenanthridines: novel dopamine D3 receptor ligandsV J Watts, C P Lawler, T Knoerzer, et al.
Clinical and Experimental Pharmacology & Physiology|March 4, 2000
Viral-mediated gene delivery of constitutively activated G alpha s alters vasoreactivityW E Schutzer, V J Watts, J Chapman, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1990
Sodium-dependent isomerization of dopamine D-2 receptors characterized using [125I]epidepride, a high-affinity substituted benzamide ligandK A Neve, R A Henningsen, J M Kinzie, et al.
Biochemical Pharmacology|November 15, 1988
Interaction of beta-adrenergic receptors with the inhibitory guanine nucleotide-binding protein of adenylate cyclase in membranes prepared from cyc- S49 lymphoma cellsS N Abramson, M W Martin, A R Hughes, et al.
Molecular Endocrinology (Baltimore, Md.)|July 21, 2001
Regulation of melatonin 1a receptor signaling and trafficking by asparagine-124C S Nelson, M Ikeda, H S Gompf, et al.
Pageof 6